Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


Dysregulated miRNAs mark Parkinson’s disease progression

Biomarkers for Parkinson’s disease are critical to our efforts to identify disease-modifying therapies. Kern et al. document potential microRNA (miRNA) biomarkers and trends in miRNA regulation that occur in a bimodal distribution with age.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: Dysregulation of miRNAs in two distinct waves during progression of PD.


  1. 1.

    Stocchi, F. & Olanow, C. W. Movement Disord. 28, 3–7 (2013).

    CAS  Article  Google Scholar 

  2. 2.

    Kern, F. et al. Nat. Aging (2021).

  3. 3.

    Marek, K. et al. Ann. Clin. Transl. Neur. 5, 1460–1477 (2018).

    CAS  Article  Google Scholar 

  4. 4.

    Rosenthal, L. S. et al. Movement Disord. 31, 915–923 (2016).

    CAS  Article  Google Scholar 

  5. 5.

    Mohammadi, D. Lancet Neurol. 12, 739–740 (2013).

    Article  Google Scholar 

  6. 6.

    Martins, M. et al. PLoS ONE 6, e25443 (2011).

    CAS  Article  Google Scholar 

  7. 7.

    Caggiu, E. et al. eNeurologicalSci 13, 1–4 (2018).

    Article  Google Scholar 

  8. 8.

    Chi, J. et al. Front. Aging Neurosci. 10, 178 (2018).

    Article  Google Scholar 

  9. 9.

    Ravanidis, S. et al. Ann. Clin. Transl. Neur. 7, 1594–1607 (2020).

    CAS  Article  Google Scholar 

  10. 10.

    Ferguson, L. W., Rajput, A. H. & Rajput, A. Can. J. Neurol. Sci. 43, 113–119 (2016).

    Article  Google Scholar 

  11. 11.

    Mehanna, R. et al. Parkinsonism Relat. D. 20, 530–534 (2014).

    Article  Google Scholar 

  12. 12.

    Goodsaid, F. M. & Mendrick, D. L. Sci. Transl. Med. 2, 47ps44 (2010).

    Article  Google Scholar 

  13. 13.

    List of qualified biomarkers. U.S. Food and Drug Administration (2021).

Download references

Author information



Corresponding author

Correspondence to Liana S. Rosenthal.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Rosenthal, L.S., Yang, J. & Mao, X. Dysregulated miRNAs mark Parkinson’s disease progression. Nat Aging 1, 241–242 (2021).

Download citation


Quick links